Clinical Trial Update: Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating lenalidomide in combination with docetaxel and prednisone in castration-resistant prostate cancer completed, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• PREDNISONE (Prednisone)
• Revlimid (lenalidomide)
• Taxotere (docetaxel)

Snippet

Sponsor: Celgene | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-09-05